SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-085763
Filing Date
2016-03-03
Accepted
2016-03-03 14:46:58
Documents
8
Period of Report
2016-02-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v433314_8k.htm 8-K 25666
2 EXHIBIT 10.1 v433314_ex10-1.htm EX-10.1 220354
3 EXHIBIT 10.2 v433314_ex10-2.htm EX-10.2 95463
4 EXHIBIT 10.3 v433314_ex10-3.htm EX-10.3 73218
5 EXHIBIT 99.1 v433314_ex99-1.htm EX-99.1 12478
6 GRAPHIC tex10-3logo.jpg GRAPHIC 6746
7 GRAPHIC tex99-1logo.jpg GRAPHIC 14305
8 GRAPHIC tex99-1line.jpg GRAPHIC 996
  Complete submission text file 0001144204-16-085763.txt   459172
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 161480654
SIC: 2834 Pharmaceutical Preparations